| | Business Summary | | Lincare
Holdings
Inc.,
together
with
its
subsidiaries,
is
a
provider
of
oxygen
and
other
respiratory
therapy
services
to
patients
in
the
home.
The
Company's
customers
typically
suffer
from
chronic
obstructive
pulmonary
disease
(COPD),
such
as
emphysema,
chronic
bronchitis
or
asthma,
and
require
supplemental
oxygen
or
other
respiratory
therapy
services
in
order
to
alleviate
the
symptoms
and
discomfort
of
respiratory
dysfunction.
Besides
providing
oxygen
and
other
respiratory
therapy
services
to
patients
in
the
home,
Lincare
also
provides
a
variety
of
infusion
therapies
in
certain
geographic
markets.
Lincare
also
supplies
home
medical
equipment,
such
as
hospital
beds,
wheelchairs
and
other
supplies
that
may
be
required
by
patients. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | Lincare
Holdings,
Inc.
provides
oxygen
and
other
respiratory
therapy
services
to
patients
in
the
home.
LNCR
also
provides
infusion
therapy
services
and
supplies
home
medical
equipment.
For
the
six
months
ended
6/30/01,
revenues
rose
19%
to
$390
million.
Net
income
rose
21%
to
$66.9
million.
Revenues
reflect
the
underlying
growth
in
the
market
for
the
Company's
services
and
acquisitions.
Net
income
also
reflects
cost
control
efforts
and
higher
margins. | | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| John Byrnes, 42
Chairman,
Pres, CEO | $1.2M | $11.4M | Paul Gabos, 51
CFO,
Sec. | 604K | 6.4M | Shawn Schabel
COO | 557K | 1.6M | | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/l/lncr.gif)